John Ransom
Stock Analyst at Raymond James
(4.54)
# 285
Out of 4,641 analysts
225
Total ratings
64.1%
Success rate
14.9%
Average return
Main Sectors:
Stocks Rated by John Ransom
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| THC Tenet Healthcare | Maintains: Strong Buy | $130 → $175 | $157.62 | +11.03% | 16 | Jul 25, 2024 | |
| GDRX GoodRx Holdings | Upgrades: Outperform | $10 | $6.54 | +52.91% | 2 | May 16, 2024 | |
| RDNT RadNet | Maintains: Outperform | $50 → $60 | $67.61 | -11.26% | 10 | May 10, 2024 | |
| EHC Encompass Health | Reiterates: Strong Buy | $85 → $95 | $95.66 | -0.69% | 15 | Apr 26, 2024 | |
| WBA Walgreens Boots Alliance | Maintains: Market Perform | n/a | $9.35 | - | 7 | Mar 26, 2024 | |
| AMED Amedisys | Maintains: Market Perform | n/a | $97.31 | - | 14 | Mar 26, 2024 | |
| HUM Humana | Initiates: Market Perform | n/a | $258.65 | - | 1 | Mar 22, 2024 | |
| OSCR Oscar Health | Initiates: Outperform | $20 | $15.94 | +25.47% | 1 | Mar 22, 2024 | |
| PHR Phreesia | Reiterates: Outperform | $25 → $30 | $18.40 | +63.04% | 12 | Mar 15, 2024 | |
| HCA HCA Healthcare | Maintains: Outperform | $300 → $330 | $410.03 | -19.52% | 20 | Jan 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $12 → $16 | $3.20 | +400.00% | 3 | Jan 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Strong Buy | $10 → $12 | $10.54 | +13.85% | 9 | Jan 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $75 → $70 | $76.76 | -8.81% | 11 | Oct 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Strong Buy | $310 → $330 | $317.57 | +3.91% | 16 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $90 → $85 | $56.78 | +49.70% | 7 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $100 → $105 | $129.39 | -18.85% | 8 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $8 → $10 | $5.32 | +87.97% | 4 | Aug 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $5.11 | - | 7 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $8.08 | - | 11 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $19.89 | - | 7 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Strong Buy | $630 | $564.64 | +11.58% | 12 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Strong Buy | $85 → $100 | $50.76 | +97.01% | 8 | Aug 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Market Perform | n/a | $5.55 | - | 7 | Feb 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $52.67 | - | 2 | Feb 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $28.63 | - | 2 | Dec 20, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $162.78 | - | 8 | Nov 7, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $59.40 | - | 3 | Mar 21, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $31.55 | - | 2 | Aug 9, 2017 |
Tenet Healthcare
Jul 25, 2024
Maintains: Strong Buy
Price Target: $130 → $175
Current: $157.62
Upside: +11.03%
GoodRx Holdings
May 16, 2024
Upgrades: Outperform
Price Target: $10
Current: $6.54
Upside: +52.91%
RadNet
May 10, 2024
Maintains: Outperform
Price Target: $50 → $60
Current: $67.61
Upside: -11.26%
Encompass Health
Apr 26, 2024
Reiterates: Strong Buy
Price Target: $85 → $95
Current: $95.66
Upside: -0.69%
Walgreens Boots Alliance
Mar 26, 2024
Maintains: Market Perform
Price Target: n/a
Current: $9.35
Upside: -
Amedisys
Mar 26, 2024
Maintains: Market Perform
Price Target: n/a
Current: $97.31
Upside: -
Humana
Mar 22, 2024
Initiates: Market Perform
Price Target: n/a
Current: $258.65
Upside: -
Oscar Health
Mar 22, 2024
Initiates: Outperform
Price Target: $20
Current: $15.94
Upside: +25.47%
Phreesia
Mar 15, 2024
Reiterates: Outperform
Price Target: $25 → $30
Current: $18.40
Upside: +63.04%
HCA Healthcare
Jan 31, 2024
Maintains: Outperform
Price Target: $300 → $330
Current: $410.03
Upside: -19.52%
Jan 9, 2024
Maintains: Outperform
Price Target: $12 → $16
Current: $3.20
Upside: +400.00%
Jan 9, 2024
Maintains: Strong Buy
Price Target: $10 → $12
Current: $10.54
Upside: +13.85%
Oct 3, 2023
Maintains: Outperform
Price Target: $75 → $70
Current: $76.76
Upside: -8.81%
Aug 7, 2023
Maintains: Strong Buy
Price Target: $310 → $330
Current: $317.57
Upside: +3.91%
Aug 4, 2023
Maintains: Outperform
Price Target: $90 → $85
Current: $56.78
Upside: +49.70%
Aug 2, 2023
Maintains: Outperform
Price Target: $100 → $105
Current: $129.39
Upside: -18.85%
Aug 1, 2023
Maintains: Outperform
Price Target: $8 → $10
Current: $5.32
Upside: +87.97%
May 12, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $5.11
Upside: -
May 10, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $8.08
Upside: -
May 3, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $19.89
Upside: -
Apr 17, 2023
Maintains: Strong Buy
Price Target: $630
Current: $564.64
Upside: +11.58%
Aug 1, 2022
Maintains: Strong Buy
Price Target: $85 → $100
Current: $50.76
Upside: +97.01%
Feb 20, 2020
Upgrades: Market Perform
Price Target: n/a
Current: $5.55
Upside: -
Feb 14, 2020
Downgrades: Market Perform
Price Target: n/a
Current: $52.67
Upside: -
Dec 20, 2019
Initiates: Market Perform
Price Target: n/a
Current: $28.63
Upside: -
Nov 7, 2019
Downgrades: Market Perform
Price Target: n/a
Current: $162.78
Upside: -
Mar 21, 2018
Upgrades: Outperform
Price Target: n/a
Current: $59.40
Upside: -
Aug 9, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $31.55
Upside: -